# TD-1607 MAD Study in Healthy Subjects

> **NCT01949103** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 48 (actual)

## Conditions studied

- Infections
- Bacterial Infections

## Interventions

- **DRUG:** TD-1607
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01949103
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01949103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01949103, "TD-1607 MAD Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01949103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*